“Multiple myeloma red flag”的搜索结果，显示 91-100 项，共有 11009 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Multiple Myeloma (SMM), who are at a High Risk (HR) of developing active multiple myeloma. The aim of this study is to find out whether linvoseltamab is ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to find the maximum tolerated dose of iberdomide for patients newly diagnosed with multiple myeloma, and to determine response rate ...

4. 血液科- 临床试验- 妙佑医疗国际

   ... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to find the maximum tolerated dose of iberdomide for patients newly diagnosed with multiple myeloma, and to determine response rate ...

6. 血液科- 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

7. 血液科- 临床试验- 妙佑医疗国际

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

8. 血液科- 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study of JNJ‐68284528 Out‐of‐Specification (OOS) for Commercial Release in Patients with Multiple Myeloma. Rochester, Minn. The purpose of this study is to ...

10. 血液科- 临床试验- 妙佑医疗国际

    This clinical trial evaluates the impact of preexisting and therapy-emergent germline and somatic variants on cytopenia in patients with multiple myeloma or ...